2010 KSR Guidelines Update, 75 FR (September 1, 2010) Updated PTO guidelines on obviousness determinations in a post KSR World

Size: px
Start display at page:

Download "2010 KSR Guidelines Update, 75 FR (September 1, 2010) Updated PTO guidelines on obviousness determinations in a post KSR World"

Transcription

1 2010 KSR Guidelines Update, 75 FR (September 1, 2010) Updated PTO guidelines on obviousness determinations in a post KSR World ROY D. GROSS Associate St. Onge Steward Johnston & Reens LLC Stamford, Connecticut This Article examines relevant caselaw discussing the obviousness doctrine, outlined in the 2010 KSR Guidelines Update, 75 FR , and the effect of this recent caselaw on patent practitioners. INTRODUCTION In order for a patent to issue, one of the requirements is that the patent must satisfy 35 U.S.C This statute sets forth that a patent may not be obtained if the differences between the subject matter sought to be patented and the prior art are such that the subject matter as a whole would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. Whether a patent is obvious over the prior art has always been and continues to be a difficult question that is decided on a case-by-case basis. In 2007, the U.S. Supreme Court, in KSR Int l Co. v. Teleflex Inc., 550 U.S. 398 (2007), analyzed the factual inquiries for a determination of obviousness and established a framework on how the obviousness determination should be made. Recent Federal Circuit cases have since analyzed the KSR v. Teleflex opinion and have provided further instruction for patent practitioners on the doctrine of obviousness. Part I of this Article examines the KSR v. Teleflex decision. Part II provides a brief discussion of relevant post-ksr decisions that further expand upon the obviousness doctrine. Part III sets forth suggestions for patent practitioners in a post-ksr landscape. I. KSR V. TELEFLEX Prior to the 2007 U.S. Supreme Court decision in KSR v. Teleflex, patent examiners were instructed to apply the teaching-suggestion-motivation test (TSM) when making a determination on whether a patent claim was obvious over the prior art. The TSM test involved analyzing whether the prior art suggests or teaches to combine elements in the prior art in order to find a patent obvious and whether the prior art suggests the desirability, and thus the obvious nature, of the combination of previously known elements. The KSR opinion, however, changed the landscape for patent examiners and practitioners, as it explained that the TSM test is just but one possible approach, and is not the sole approach to be followed when making an obviousness determination. Id., 550 U.S. at 415. Instead, KSR outlined a more flexible approach for determining obviousness, and set forth six different rationales for this determination. These rationales, identified in the initial 2007 KSR Guidelines from the USPTO include: (1) combining prior art elements according to known methods to yield predictable results; (2) 1

2 simple substitution of one known element for another to obtain predictable results; (3) use of a known technique to improve similar devices, methods, or products in the same way; (4) applying a known technique to a known device, method, or product ready for improvement to yield predictable results; (5) obvious to try choosing from a finite number of identified, predictable solutions, with a reasonable expectation of success; and (6) known work in one field of endeavor may prompt variations of it for use in either the same field or a different one based on design incentives or other market forces if the variations are predictable to one of ordinary skill in the art. 72 Fed. Reg (2007 KSR Guidelines). When considering obviousness, the flexible post-ksr approach allows patent examiners to support a rejection under 35 U.S.C. 103 by reliance on scientific theory and legal precedent, while employing one of the above six mentioned rationales. However, such rationales are not per se rules, and patent examiners are required to clearly identify and explain the bases for their rejections and how to apply the facts at hand for each rationale to support an obviousness rejection. On September 1, 2010, the USPTO issued new KSR guidelines ( the 2010 KSR Guidelines ) to provide a more complete view of developments in the law of obviousness for patent examiners and practitioners, as the body of case law regarding obviousness has developed following the 2007 KSR opinion. Such guidelines, following key Federal Circuit decisions, provide further analysis on three groups of rationales identified by the 2007 KSR Guidelines combining prior art elements, substituting one known element for another and obvious to try. Significant cases in these rationales are discussed below. II. RATIONALES FROM POST-KSR CASES a. COMBINING PRIOR ART ELEMENTS TO YIELD PREDICTABLE RESULTS Post-KSR, one of the rationales for establishing an obviousness rejection is when components are known in the prior art, and when it would be foreseeable for persons of ordinary skill in the art to combine these prior art components to yield predictable results. However, when the step of combining prior art references involves additional effort that no one of ordinary skill in the art would have undertaken without a recognized reason, then the combination invention is beyond what is a predictable result and may be unobvious over the prior art. Two cases discuss this principle, and arrive at different outcomes. i. ECOLAB. V. FMC (CLAIMS FOUND OBVIOUS) The Federal Circuit, in Ecolab, Inc. v. FMC Corp., 569 F.3d 1335 (Fed. Cir. 2009), found that a combination of known elements would have been prima facie obvious if an ordinarily skilled artisan would have recognized an apparent reason to combine those elements and would have known how to do so. In Ecolab, the claimed invention was directed to a method for sanitizing meat by spraying the meat with an antibacterial solution under specified conditions. A prior art reference asserted for invalidity of the claimed method was found to disclose all elements 2

3 of the method, except for the pressure limitation of spraying the meat at a pressure of at least 50 psi (pounds per square inch). Id., 569 F.3d at The Federal Circuit found the method to be obvious because there was an apparent reason to combine known elements namely to increase the contact between the antibacterial solution and the bacteria on the meat surface by spraying the meat at a high pressure of at least 50 psi to wash additional bacteria off the meat surface. Id., 569 F.3d at The Federal Circuit explained that a person of skill in the art would have recognized the reason to use high pressure to spray the antibacterial solution onto meat and thus, found the method claims to be obvious over the primary prior art reference and a secondary reference, which taught using pressure of 20 to 150 psi to vigorously wash a meat surface. Thus, the Ecolab decision supports the principle that if a claimed invention is merely the combination of familiar elements which yield predictable results, then the claimed invention is obvious. ii. IN RE OMEPRAZOLE PATENT LITIGATION (CLAIMS FOUND UNOBVIOUS) The Federal Circuit reached a contrary conclusion in In re Omeprazole Pat. Lit., 536 F.3d 1361 (Fed. Cir. 2008). In Omeprazole, the claimed invention was directed to an enteric coating for an omeprazole pill for the purpose of ensuring that the active omeprazole drug did not disintegrate before reaching its intended site of action. The Defendant argued that coated omeprazole tablets were known from a prior art reference and that subcoatings for enteric drug formulation were generally known. The Defendant also argued that there was no evidence of undue technical hurdles or lack of a reasonable expectation of success to create an omeprazole pill with an enteric coating, and therefore, the enteric coating of the claimed invention was obvious over the prior art. The Federal Circuit, however, disagreed and found that the problem of degradation of omeprazole by interaction with an enteric coating had not been recognized in the prior art. Therefore, a person of skill in the art would have had no reason to include an additional subcoating in an omeprazole pill formulation, even though the addition of a subcoating could have been done by a person of skill in the art. Thus, the Omeprazole decision explains that even where the modifications necessary to arrive at the claimed invention were known, a claimed invention may be unobvious, if the problem which would have motivated a person of skill in the art to make these modifications was previously unknown. b. SUBSTITUTING ONE KNOWN ELEMENT FOR ANOTHER A second rationale described in the KSR opinion for an obviousness rejection is the substitution rationale. The substitution rationale involves an Examiner substituting a known element from one prior art reference for another prior art reference to render the claimed invention obvious. This rationale may be applied when one of ordinary skill in the art would have been technologically capable of making the substitution, and the result obtained would have been predictable. Two cases discuss this principle, and arrive at different results. 3

4 i. IN RE ICON HEALTH & FITNESS (CLAIMS FOUND OBVIOUS) The Federal Circuit, in In re ICON Health & Fitness, Inc., 496 F.3d 1374 (Fed. Cir. 2007), analyzed when a prior art reference is proper to support a case of obviousness via the substitution rationale. The claimed invention in ICON was directed to a treadmill with a folding base that swivels via a gas spring. The Federal Circuit evaluated whether a secondary prior reference that taught gas springs could be used as a substitution in an obviousness analysis with a reference for a treadmill, even though the secondary reference did not have any particular focus on treadmills. The ICON Court held that this secondary reference was properly applied in connection with a rejection of claims directed to a treadmill invention because the reference considered the problem to be solved (i.e. supporting the weight of a folding mechanism and providing a stable resting position via a spring). The secondary reference was considered to be analogous art for solving the problem of the claimed invention and the ICON Court held that the secondary reference, by addressing a similar problem, was proper for a substitution analysis for obviousness, as it indicated a reason to incorporate its teaching into the primary reference. Id., at Thus, the ICON decision supports the principle that when determining whether a reference in a different field of endeavor may be used in a substitution to support a case of obviousness, it is necessary to consider the problem to be solved by the claimed invention. ii. EISAI V. DR. REDDY S LABS (CLAIMS FOUND UNOBVIOUS) The Federal Circuit reached a contrary conclusion regarding the substitution rationale in Eisai Co. Ltd. v. Dr. Reddy s Labs., Ltd., 533 F.3d 1353 (Fed. Cir. 2008). In Eisai, the Federal Circuit analyzed the claimed invention for the pharmaceutical compound rabeprazole. The Defendant based its obviousness argument on the structural similarity of rabeprazole and lansoprazole, a compound discussed in a prior art reference. The Defendant argued that starting with lansoprazole, it was obvious for a person of skill in the art to arrive at rabeprazole. However, despite the significant similarity between the structures of lansoprazole and rabeprazole, the Federal Circuit did not find any sufficient reason to modify the rabeprazole compound based upon the prior art lansoprazole compound. The Court said that there must be a reason for starting with a lead compound (lansoprazole) and modifying it to arrive at the claimed compound (rabeprazole) in order to support an obvious rejection. Thus, without a reasonable expectation of success, the Court found that it would not have been obvious to arrive at the claimed compound where there was no reason to modify the closest prior art lead compound, as this was not an identifiable predictable solution. Eisai is an example where a substitution would not have been obvious. c. OBVIOUS TO TRY A third rationale recognized by the KSR opinion is the obvious to try rationale. The obvious to try rationale is only appropriate when there are a finite number of 4

5 identified, predictable solutions to the recognized need or problem, and one of ordinary skill in the art could have pursued these known potential solutions with a reasonable expectation of success. Two cases discuss this principle, and arrive at different results. i. ROLLS-ROYCE V. UNITED TECHS. (CLAIMS FOUND UNOBVIOUS) The Federal Circuit, in Rolls-Royce, PLC v. United Techs. Corp., 603 F.3d 1325 (Fed. Cir. 2010), found that a claimed invention may be found obvious when the possible options for solving a problem were known and finite. In Rolls-Royce, the invention was directed to a fan blade for jet engines. The claimed invention was a fan blade design where the asserted novelty of the new design was directed to the sweep angle of the blade. The sweep angle in the outer region of the claimed invention was reversed compared with prior art fan blades in order to reduce endwall shock in the jet engine. The Federal Circuit, in its analysis, acknowledged that there was no suggestion in the prior art that changing the sweep angle would have addressed the issue of endwall shock. Thus, changing the sweep angle would not have presented itself as an option at all, let alone an option that would have been obvious to try. Id., 603 F.3d at The decision in Rolls-Royce supports the conclusion that the obvious to try rationale can properly be used for a finding of obviousness only when the claimed solution would have been selected from a finite number of potential solutions known to persons of ordinary skill in the art. ii. PERFECT WEB TECHS., INC. V. INFOUSA (CLAIMS FOUND OBVIOUS) The Federal Circuit reached a contrary conclusion regarding obvious to try in Perfect Web Techs., Inc. v. InfoUSA, Inc., 587 F.3d 1324 (Fed. Cir. 2009). In Perfect Web, the claimed invention was directed to a method for managing bulk distribution involving selecting intended recipients, transmitting s, determining how many of the s had been successfully received, and repeating the previous steps if a predetermined minimum number of intended recipients had not received the . The Federal Circuit held that there was no evidence of any unexpected results associated with selecting a new recipient list and no evidence that the method would not have had a reasonable likelihood of success. Thus, as there were a finite number of identified predictable solutions, the obvious to try inquiry properly led to the legal conclusion of obviousness as it was common sense, and the claim as a whole, simply recites repetition of a known procedure until success is achieved. Id., 587 F.3d at Thus, Perfect Web reaches a contrary conclusion to Rolls-Royce because common sense would allow a person of skill in the art to select from a finite number of potential solutions known to persons of ordinary skill in the art to arrive at the claimed invention. III. SUGGESTIONS FOR PATENT PRACTITIONERS As discussed above, recent Federal Circuit caselaw outlined in the 2010 KSR Guidelines sheds additional light on rationales for obviousness determinations. Patent practitioners need to be aware of and consider these obviousness rationales combining 5

6 prior art elements to yield predictable results, substituting one known element for another, and the obvious to try rationale when drafting patent applications. The good news for patent practitioners is that familiar lines of argument still apply, including teaching away from the claimed invention by prior art, lack of a reasonable expectation of success, and unexpected results, which can help show that claims are unobvious. With regard to the rationale of combining prior art elements to yield predictable results, patent practitioners may now consider, during the patent drafting process, working with inventors to identify the unknown problems and needs that the claimed invention solves and highlighting the existence of these problems in a patent specification. Working with inventors to add disclosure to the specification on why the claimed invention does not achieve a predictable result of elements may reduce the likelihood of receiving an obviousness rejection and/or may provide a basis of arguing against such a rejection when received. To overcome the obvious to try rationale, practitioners should be vigilant in discussing with their clients to include discussion of unexpected results in the patent specification on how the claimed invention has advantages over the prior art that a person of skill the art would not have considered. Thus, considering the new 2010 KSR guidelines, patent practitioners should take additional care when drafting patent applications and should consider the new obviousness rationales set forth by KSR to anticipate potential obviousness rejections that may arise during patent prosecution. 6

Duh! Finding the Obvious in a Patent Application

Duh! Finding the Obvious in a Patent Application Duh! Finding the Obvious in a Patent Application By: Tom Bakos, FSA, MAAA Co-Editor, Insurance IP Bulletin Patents may be granted in the U.S. for inventions that are new and useful. The term new means

More information

Winning a Non-Obviousness Case at the Board

Winning a Non-Obviousness Case at the Board Winning a Non-Obviousness Case at the Board Michael Messinger Director, Electrical and Clean Tech April 22, 2010 Obvious Not Obvious 2 Ratcheting Up a Non-Obviousness Position Attack with Argument Only

More information

The patentability criteria for inventive step I nonobviousness. The Groups are invited to answer the following questions under their national laws:

The patentability criteria for inventive step I nonobviousness. The Groups are invited to answer the following questions under their national laws: Question Q217 National Group: United States Title: The patentability criteria for inventive step I nonobviousness Contributors: Marc V. Richards Chair Alan Kasper Drew Meunier Joshua Goldberg Dan Altman

More information

When Is An Invention. Nevertheless Nonobvious?

When Is An Invention. Nevertheless Nonobvious? When Is An Invention That Was Obvious To Try Nevertheless Nonobvious? This article was originally published in Volume 23, Number 3 (March 2014) of The Federal Circuit Bar Journal by the Federal Circuit

More information

November Common Sense Approach to Obviousness. g Obvious to Try. g Obviousness-Type Double Patenting

November Common Sense Approach to Obviousness. g Obvious to Try. g Obviousness-Type Double Patenting Federal Circuit Review Obviousness Volume Three Issue Two November 2010 In This Issue: g Common Sense Approach to Obviousnesss g Obvious to Try g Obviousness-Type Double Patenting = Pharmaceutical Compounds

More information

KSR INTERNATIONAL CO. v. TELEFLEX INC.: Analysis and Potential Impact for Patentees

KSR INTERNATIONAL CO. v. TELEFLEX INC.: Analysis and Potential Impact for Patentees KSR INTERNATIONAL CO. v. TELEFLEX INC.: Analysis and Potential Impact for Patentees Keith D. Lindenbaum, J.D. Partner, Mechanical & Electromechanical Technologies Practice and International Business Industry

More information

New Obviousness Guidelines from the USPTO and Their Impact on Prosecution

New Obviousness Guidelines from the USPTO and Their Impact on Prosecution New Obviousness Guidelines from the USPTO and Their Impact on Prosecution Anthony C. Tridico & Carlos M. Téllez MAY 9, 2011 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, 2011 1 Disclaimer These

More information

Obviousness Doctrine Post-KSR: Friend or Foe?

Obviousness Doctrine Post-KSR: Friend or Foe? INTELLECTUAL PROPERTY DESK REFERENCE PATENTS, TRADEMARKS, COPYRIGHTS AND RELATED TOPICS PATENT Obviousness Doctrine Post-KSR: Friend or Foe? Steven Gardner and Nicole N. Morris WWW.KILPATRICKSTOCKTON.COM

More information

KSR International Co. v. Teleflex Inc.: Patentability Clarity or Confusion?

KSR International Co. v. Teleflex Inc.: Patentability Clarity or Confusion? Northwestern Journal of Technology and Intellectual Property Volume 6 Issue 2 Spring Article 4 Spring 2008 KSR International Co. v. Teleflex Inc.: Patentability Clarity or Confusion? Recommended Citation,

More information

In re Metoprolol Succinate Obviousness-Type Double Patenting Walter B. Welsh St. Onge Steward Johnston & Reens LLC Stamford, Connecticut

In re Metoprolol Succinate Obviousness-Type Double Patenting Walter B. Welsh St. Onge Steward Johnston & Reens LLC Stamford, Connecticut In re Metoprolol Succinate Obviousness-Type Double Patenting Walter B. Welsh St. Onge Steward Johnston & Reens LLC Stamford, Connecticut I. INTRODUCTION In Metoprolol Succinate the Court of Appeals for

More information

Inventive Step and Non-obviousness: Global Perspectives

Inventive Step and Non-obviousness: Global Perspectives Primer Encuentro Internacional AMPPI First International AMPPI Conference Inventive Step and Non-obviousness: Global Perspectives www.usebrinks.com Marc V. Richards March 23, 2012 Isn t it Obvious? 2 The

More information

KSR. Managing Intellectual Property May 30, Rick Frenkel Cisco Systems Kevin Rhodes 3M Kathi Kelly Lutton F&R John Dragseth F&R

KSR. Managing Intellectual Property May 30, Rick Frenkel Cisco Systems Kevin Rhodes 3M Kathi Kelly Lutton F&R John Dragseth F&R KSR Managing Intellectual Property May 30, 2007 Rick Frenkel Cisco Systems Kevin Rhodes 3M Kathi Kelly Lutton F&R John Dragseth F&R Overview The Patent The Procedure The Quotes The PTO Discussion ƒ Impact

More information

In the Wake of KSR: Sea Change or Wait-and-See?

In the Wake of KSR: Sea Change or Wait-and-See? In the Wake of KSR: Sea Change or Wait-and-See? Tom Elkind Partner Foley & Lardner LLP Roger Kitterman Associate Director Center for Innovative Ventures, Partners Healthcare Curtis Rose Assistant General

More information

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 -

COMPARATIVE STUDY REPORT TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 - COMPARATIVE STUDY REPORT ON TRILATERAL PROJECT 12.4 INVENTIVE STEP - 1 - CONTENTS PAGE COMPARISON OUTLINE COMPARATIVE ANALYSIS I. Determining inventive step 1 1 A. Judicial, legislative or administrative

More information

KSR International Co., v. Teleflex Inc. U.S. Supreme Court, April 2007

KSR International Co., v. Teleflex Inc. U.S. Supreme Court, April 2007 KSR International Co., v. Teleflex Inc. U.S. Supreme Court, April 2007 Abraham J. Rosner Sughrue Mion, PLLC INTRODUCTION In KSR International Co. v. Teleflex Inc., 127 S.Ct. 1727 (2007), the Supreme Court

More information

November Obvious To Try In Pharmaceutical Formulations. g Motivation To Combine. g Obviousness-Type Double Patenting

November Obvious To Try In Pharmaceutical Formulations. g Motivation To Combine. g Obviousness-Type Double Patenting Federal Circuit Review Obviousness Volume Two Issue Two November 2009 In This Issue: g Obvious To Try In Pharmaceutical Formulations g Motivation To Combine g Obviousness-Type Double Patenting = Product-Process

More information

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness

Working Guidelines Q217. The patentability criteria for inventive step / non-obviousness Working Guidelines by Thierry CALAME, Reporter General Nicola DAGG and Sarah MATHESON, Deputy Reporters General John OSHA, Kazuhiko YOSHIDA and Sara ULFSDOTTER Assistants to the Reporter General Q217 The

More information

2009 Howrey LLP 1 COMMON USPTO REJECTIONS COMMON USPTO REJECTIONS OBVIOUSNESS. Learned Hand on Obviousness. The Graham Factors

2009 Howrey LLP 1 COMMON USPTO REJECTIONS COMMON USPTO REJECTIONS OBVIOUSNESS. Learned Hand on Obviousness. The Graham Factors COMMON USPTO REJECTIONS IMPORTANT CASE LAW and RECENT PHAMA CASE LAW Viola T. Kung, Ph.D. Prior art rejections 35 U.S.C 102, Novelty 35 U.S.C 103, Obviousness Supreme court case: KSR June 2009 2 COMMON

More information

Pharmaceutical Formulations: Ready For Patenting?

Pharmaceutical Formulations: Ready For Patenting? Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Pharmaceutical Formulations: Ready For Patenting?

More information

Paper No Entered: January 7, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Paper No Entered: January 7, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Trials@uspto.gov Paper No. 10 571-272-7822 Entered: January 7, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD TORRENT PHARMACEUTICALS LIMITED, Petitioner, v. MERCK

More information

OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW

OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW OLIVE & OLIVE, P.A. INTELLECTUAL PROPERTY LAW Since 1957 500 MEMORIAL ST. POST OFFICE BOX 2049 DURHAM, NORTH CAROLINA 27702-2049 (919) 683-5514 GENERAL RULES PERTAINING TO PATENT INFRINGEMENT Patent infringement

More information

Five Winning Strategies for Crafting Claims in U.S. Patent Applications

Five Winning Strategies for Crafting Claims in U.S. Patent Applications Page 1 Five Winning Strategies for Crafting Claims in U.S. Patent Applications, is a registered patent attorney and chair of the Intellectual Property and Technology Practice Group at Bond, Schoeneck &

More information

Comments on KSR Int'l Co. v. Teleflex, Inc.

Comments on KSR Int'l Co. v. Teleflex, Inc. Banner & Witcoff Intellectual Property Advisory Comments on KSR Int'l Co. v. Teleflex, Inc. By Joseph M. Potenza On April 30, 2007, the U.S. Supreme Court came out with the long-awaited decision clarifying

More information

Adjusting the Rearview Mirror - - Blocking Impermissible Hindsight Rejections By Warren D. Woessner 1

Adjusting the Rearview Mirror - - Blocking Impermissible Hindsight Rejections By Warren D. Woessner 1 Adjusting the Rearview Mirror - - Blocking Impermissible Hindsight Rejections By Warren D. Woessner 1 Grounded in Graham v. Deere 2 and acknowledged in KSR International Co. v. Teleflex Inc., 3 the prohibition

More information

The Patentability Search

The Patentability Search Chapter 5 The Patentability Search 5:1 Introduction 5:2 What Is a Patentability Search? 5:3 Why Order a Patentability Search? 5:3.1 Economics 5:3.2 A Better Application Can Be Prepared 5:3.3 Commercial

More information

Patent Prosecution. Decisions Relating to Obviousness Rejections Under 35 U.S.C. 103

Patent Prosecution. Decisions Relating to Obviousness Rejections Under 35 U.S.C. 103 Patent Prosecution Decisions Relating to Obviousness Rejections Under 35 U.S.C. 103 1) Graham v. John Deere (148 USPQ 459) A. For a determination of obviousness of the subject matter under 35 U.S.C 103,

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit NOTE: Pursuant to Fed. Cir. R. 47.6, this disposition is not citable as precedent. It is a public record. United States Court of Appeals for the Federal Circuit 02-1247 RONALD E. ROGERS, Plaintiff-Appellant,

More information

Inventive Step. Japan Patent Office

Inventive Step. Japan Patent Office Inventive Step Japan Patent Office Outline I. Overview of Inventive Step II. Procedure of Evaluating Inventive Step III. Examination Guidelines in JPO 1 Outline I. Overview of Inventive Step II. Procedure

More information

Paper Entered: April 21, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Paper Entered: April 21, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Trials@uspto.gov Paper 10 571-272-7822 Entered: April 21, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD KASPERSKY LAB, INC., Petitioner, v. UNILOC USA, INC. and

More information

PATENT DISCLOSURE: Meeting Expectations in the USPTO

PATENT DISCLOSURE: Meeting Expectations in the USPTO PATENT DISCLOSURE: Meeting Expectations in the USPTO Robert W. Bahr Acting Associate Commissioner for Patent Examination Policy United States Patent and Trademark Office 11/17/2016 1 The U.S. patent system

More information

Chemical Patent Practice. Course Syllabus

Chemical Patent Practice. Course Syllabus Chemical Patent Practice Course Syllabus I. INTRODUCTION TO CHEMICAL PATENT PRACTICE: SETTING THE STAGE FOR DISCUSSING STRATEGIES FOR REDUCING RISK OF UNENFORCEABILITY AND ENHANCING CHANCES OF INFRINGEMENT,

More information

JUDGES ARE ABUSING THEIR AUTHORITY TO DETERMINE OBVIOUSNESS BY APPLYING KSR WITHOUT CHANGING THE LEGAL STANDARD OF REVIEW

JUDGES ARE ABUSING THEIR AUTHORITY TO DETERMINE OBVIOUSNESS BY APPLYING KSR WITHOUT CHANGING THE LEGAL STANDARD OF REVIEW University of Cincinnati Law Review Volume 79 Issue 1 Article 8 10-17-2011 JUDGES ARE ABUSING THEIR AUTHORITY TO DETERMINE OBVIOUSNESS BY APPLYING KSR WITHOUT CHANGING THE LEGAL STANDARD OF REVIEW Colleen

More information

Patent Resources Group. Chemical Patent Practice. Course Syllabus

Patent Resources Group. Chemical Patent Practice. Course Syllabus Patent Resources Group Chemical Patent Practice Course Syllabus I. INTRODUCTION II. USER GUIDE: Overview of America Invents Act Changes with Respect to Prior Art III. DRAFTING CHEMICAL CLAIMS AND SPECIFICATION

More information

Royal Society of Chemistry Law Group. Recent Case Law Relevant to Chemistry

Royal Society of Chemistry Law Group. Recent Case Law Relevant to Chemistry Royal Society of Chemistry Law Group Recent Case Law Relevant to Chemistry Recent IP Case Law from the US Presenter: Don Lewis Topics KSR v. Teleflex and aftermath Tafas & GSK v. Dudas and aftermath New

More information

Lessons From Inter Partes Review Denials

Lessons From Inter Partes Review Denials Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Lessons From Inter Partes Review Denials Law360, New

More information

Patent Prosecution. A. For a determination of obviousness of the subject matter under 35 U.S.C

Patent Prosecution. A. For a determination of obviousness of the subject matter under 35 U.S.C Patent Prosecution Decisions Relating to Obviousness Reiections Under 35 U.S.C. 61 03(a) 1) Graham v. John Deere (148 USPQ 459) A. For a determination of obviousness of the subject matter under 35 U.S.C

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit IN RE: MARCEL VAN OS, FREDDY ALLEN ANZURES, SCOTT FORSTALL, GREG CHRISTIE, IMRAN CHAUDHRI, Appellants 2015-1975 Appeal from the United States Patent

More information

Preparing For The Obvious At The PTAB

Preparing For The Obvious At The PTAB Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Preparing For The Obvious At The PTAB Law360, New

More information

In Re Klein F.3D 1343 (Fed. Cir. 2011)

In Re Klein F.3D 1343 (Fed. Cir. 2011) DePaul Journal of Art, Technology & Intellectual Property Law Volume 22 Issue 1 Fall 2011 Article 8 In Re Klein - 647 F.3D 1343 (Fed. Cir. 2011) Allyson M. Martin Follow this and additional works at: http://via.library.depaul.edu/jatip

More information

In the Supreme Court s 2014 decision in Alice Corp. v. CLS Bank Int l, the Supreme

In the Supreme Court s 2014 decision in Alice Corp. v. CLS Bank Int l, the Supreme In the Supreme Court s 2014 decision in Alice Corp. v. CLS Bank Int l, the Supreme Court cemented a two-step framework for determining whether a patent claim is ineligible for patenting under 101. The

More information

Obvious to Try? The Slippery Slope of Biotechnology

Obvious to Try? The Slippery Slope of Biotechnology Obvious to Try? The Slippery Slope of Biotechnology Ha Kung Wong and Soma Saha, Fitzpatrick Cella Harper & Scinto I. Introduction One of the most significant hurdles in obtaining a patent is the requirement

More information

Request for Comments on Determining Whether a Claim Element is Well- Understood, Routine, Conventional for Purposes of Subject Matter Eligibility

Request for Comments on Determining Whether a Claim Element is Well- Understood, Routine, Conventional for Purposes of Subject Matter Eligibility This document is scheduled to be published in the Federal Register on 04/20/2018 and available online at https://federalregister.gov/d/2018-08428, and on FDsys.gov [3510-16-P] DEPARTMENT OF COMMERCE United

More information

KSR Int l Co. v. Teleflex, Inc.: No Obvious Changes for the Biotechnology Market

KSR Int l Co. v. Teleflex, Inc.: No Obvious Changes for the Biotechnology Market YALE JOURNAL OF BIOLOGY AND MEDICINE 80 (2007), pp.153-157. Copyright 2007. ESSAY KSR Int l Co. v. Teleflex, Inc.: No Obvious Changes for the Biotechnology Market Carl H. Hinneschiedt JD, Georgetown University

More information

Patent Owner Use of Reexamination for Patents Granted Prior to KSR v. Teleflex. Stephen G. Kunin Partner. AIPLA Webcast, April 20, 2011

Patent Owner Use of Reexamination for Patents Granted Prior to KSR v. Teleflex. Stephen G. Kunin Partner. AIPLA Webcast, April 20, 2011 Patent Owner Use of Reexamination for Patents Granted Prior to KSR v. Teleflex Stephen G. Kunin Partner AIPLA Webcast, April 20, 2011 Should Patent Owners Use Reexamination to Strengthen Patents Issued

More information

PTO PUBLISHES SUPPLEMENTAL EXAMINATION GUIDELINES FOR DETERMINING OBVIOUSNESS

PTO PUBLISHES SUPPLEMENTAL EXAMINATION GUIDELINES FOR DETERMINING OBVIOUSNESS PTO PUBLISHES SUPPLEMENTAL EXAMINATION GUIDELINES FOR DETERMINING OBVIOUSNESS September 3, 2010 On September 1, 2010, the U.S. Patent and Trademark Office (PTO) published "Examination Guidelines Update:

More information

Patent Law. Prof. Roger Ford October 19, 2016 Class 13 Nonobviousness: Scope and Content of the Prior Art. Recap

Patent Law. Prof. Roger Ford October 19, 2016 Class 13 Nonobviousness: Scope and Content of the Prior Art. Recap Patent Law Prof. Roger Ford October 19, 2016 Class 13 Nonobviousness: Scope and Content of the Prior Art Recap Recap Obviousness after KSR Objective indicia of nonobviousness Today s agenda Today s agenda

More information

Dynamic Drinkware, a Technical Trap for the Unwary

Dynamic Drinkware, a Technical Trap for the Unwary Yesterday in Dynamic Drinkware, LLC v. National Graphics, Inc., F.3d (Fed. Cir. 2015)(Lourie, J.)(and as reported in a note that day, attached), the court denied a patent-defeating effect to a United States

More information

Prosecuting Patent Applications: Establishing Unexpected Results

Prosecuting Patent Applications: Establishing Unexpected Results Page 1 of 9 Prosecuting Patent Applications: Establishing Unexpected Results The purpose of this article is to provide suggestions on how to effectively make a showing of unexpected results during prosecution

More information

Three Years Post-KSR: A Practitioner s Guide to Winning Arguments on Obviousness and a Look at What May Lay Ahead

Three Years Post-KSR: A Practitioner s Guide to Winning Arguments on Obviousness and a Look at What May Lay Ahead Northwestern Journal of Technology and Intellectual Property Volume 9 Issue 3 Fall Article 6 Fall 2010 Three Years Post-KSR: A Practitioner s Guide to Winning Arguments on Obviousness and a Look at What

More information

Fed. Circ. Radically Changes The Law Of Obviousness

Fed. Circ. Radically Changes The Law Of Obviousness Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com Fed. Circ. Radically Changes The Law Of Obviousness

More information

Patent Exam Fall 2015

Patent Exam Fall 2015 Exam No. This examination consists of five short answer questions 2 hours ******** Computer users: Please use the Exam4 software in take-home mode. Answers may alternatively be hand-written. Instructions:

More information

PATENT PROSECUTION TIPS FROM THE TRENCHES

PATENT PROSECUTION TIPS FROM THE TRENCHES PATENT PROSECUTION TIPS FROM THE TRENCHES By Marin Cionca; OCIPLA Luncheon - May 17, 2018 1. The use of Functional Claim Language in view of recent court decisions and the January 2018 update to the MPEP

More information

Examination Guidelines for Patentability - Novelty and Inventive Step. Shunsuke YAMAMOTO Examination Standards Office Japan Patent Office 2016.

Examination Guidelines for Patentability - Novelty and Inventive Step. Shunsuke YAMAMOTO Examination Standards Office Japan Patent Office 2016. Examination Guidelines for Patentability - Novelty and Inventive Step Shunsuke YAMAMOTO Examination Standards Office Japan Patent Office 2016.09 1 Outline 1. Flowchart of Determining Novelty and Inventive

More information

KSR v. TELEFLEX: HOW OBVIOUSNESS HAS CHANGED

KSR v. TELEFLEX: HOW OBVIOUSNESS HAS CHANGED KSR v. TELEFLEX: HOW OBVIOUSNESS HAS CHANGED DANIEL BECKER* A patent is invalid on obviousness grounds when the differences between the subject matter sought to be patented and the prior art are such that

More information

Monitoring Practitioner Compliance With Disciplinary Rules and Inequitable Conduct

Monitoring Practitioner Compliance With Disciplinary Rules and Inequitable Conduct Monitoring Practitioner Compliance With Disciplinary Rules and Inequitable Conduct Intellectual Property Owners Association September 11, 2007, New York, New York By Harry I. Moatz Director of Enrollment

More information

Traversing Art Rejections in Nanotechnology Patent Applications No Small Task

Traversing Art Rejections in Nanotechnology Patent Applications No Small Task Traversing Art Rejections in Nanotechnology Patent Applications No Small Task Mark Williamson and James Carpenter Abstract Courts have long held that merely changing the scale of a prior art device does

More information

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD IN THE UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD SANOFI-AVENTIS U.S. LLC, GENZYME CORP. AND REGENERON PHARMACEUTICALS, INC., Petitioners v. IMMUNEX CORPORATION,

More information

PATENT LAW DEVELOPMENTS

PATENT LAW DEVELOPMENTS PATENT LAW DEVELOPMENTS Patentable Subject Matter, Prior Art, and Post Grant Review Christine Ethridge Copyright 2014 by K&L Gates LLP. All rights reserved. DISCLAIMER The statements and views expressed

More information

MEMORANDUM. DATE: April 19, 2018 TO: FROM:

MEMORANDUM. DATE: April 19, 2018 TO: FROM: ii ~ %~fj ~ ~ ~htofeo~ UNITED STATES PATENT AND TRADEMARK OFFICE Commissioner for Patents United States Patent and Trademark Office P.O. Box 1450 Alexandria, VA 22313-1450 www.uspto.gov MEMORANDUM DATE:

More information

EFFECTS OF KSR ON PATENT PRACTICE

EFFECTS OF KSR ON PATENT PRACTICE EFFECTS OF KSR ON PATENT PRACTICE FOR: PIUG (New Brunswick, NJ, October 9, 2007) RICHARD NEIFELD, Ph.D., PATENT ATTORNEY NEIFELD IP LAW, PC - www.neifeld.com EMAIL: rneifeld@neifeld.com 4813-B EISENHOWER

More information

Interpretation of Functional Language

Interpretation of Functional Language Interpretation of Functional Language In re Chudik (Fed. Cir. January 9, 2017) Chris McDonald February 8, 2017 2016 Birch, Stewart, Kolasch & Birch, LLP MPEP - Functional Language MPEP 2173.05(g) Functional

More information

For a patent to be valid, it needs to be useful, novel, nonobvious, and adequately

For a patent to be valid, it needs to be useful, novel, nonobvious, and adequately Limin Zheng Box 650 limin@boalthall.berkeley.edu CASE REPORT: Purdue Pharma L.P. v. Faulding Inc., 230 F.3d 1320 (2000) I. INTRODUCTION For a patent to be valid, it needs to be useful, novel, nonobvious,

More information

The New PTAB: Best Practices

The New PTAB: Best Practices The New PTAB: Best Practices Los Angeles Intellectual Property Law Association Washington in the West Conference January 29, 2013 Los Angeles, California Jeffrey B. Robertson Administrative Patent Judge

More information

Paper Entered: June 3, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Paper Entered: June 3, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Trials@uspto.gov Paper 8 571-272-7822 Entered: June 3, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD SECURUS TECHNOLOGIES, INC., Petitioner, v. GLOBAL TEL*LINK

More information

Inequitable Conduct Judicial Developments

Inequitable Conduct Judicial Developments Inequitable Conduct Judicial Developments Duke Patent Law Institute May 16, 2013 Presented by Tom Irving Copyright Finnegan 2013 Disclaimer These materials are public information and have been prepared

More information

HARMONIZING THE DOCTRINES OF ENABLEMENT AND OBVIOUSNESS IN PATENT LITIGATION ABSTRACT. By Roy D. Gross. Volume XII Spring 2012

HARMONIZING THE DOCTRINES OF ENABLEMENT AND OBVIOUSNESS IN PATENT LITIGATION ABSTRACT. By Roy D. Gross. Volume XII Spring 2012 HARMONIZING THE DOCTRINES OF ENABLEMENT AND OBVIOUSNESS IN PATENT LITIGATION By Roy D. Gross Volume XII Spring 2012 ABSTRACT This Article examines the balance between advancing one s arguments that a patent

More information

Paper Entered: September 23, 2013 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Paper Entered: September 23, 2013 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Trials@uspto.gov Paper 16 571-272-7822 Entered: September 23, 2013 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD FELLOWES, INC. Petitioner v. SPECULATIVE PRODUCT DESIGN,

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit 2007-1554 ASYST TECHNOLOGIES, INC., v. Plaintiff-Appellant, EMTRAK, INC., JENOPTIK AG, JENOPTIK INFAB, INC., and MEISSNER + WURST GmbH, Defendants-Appellees.

More information

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO) COMPARATIVE STUDY REPORT ON INVENTIVE STEP (JPO - KIPO - SIPO) CONTENTS PAGE COMPARISON OUTLINE COMPARATIVE ANALYSIS I. Determining inventive step 1 1 A. Judicial, legislative or administrative criteria

More information

Post-KSR Decisions on Obviousness: Practical Implications for Patent Prosecution, Opinion and Enforcement Practice

Post-KSR Decisions on Obviousness: Practical Implications for Patent Prosecution, Opinion and Enforcement Practice Post-KSR Decisions on Obviousness: Practical Implications for Patent Prosecution, Opinion and Enforcement Practice MIPLA IP Law Revisions Roundtable April 16, 2008 Greg H. Gardella Presentation content

More information

Business Method Patents on the Chopping Block?

Business Method Patents on the Chopping Block? Business Method Patents on the Chopping Block? ACCA, San Diego Chapter General Counsel Roundtable and All Day MCLE Eric Acker and Greg Reilly Morrison & Foerster LLP San Diego, CA 2007 Morrison & Foerster

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit ENOCEAN GMBH, Appellant, v. FACE INTERNATIONAL CORPORATION, Appellee. 2012-1645 Appeal from the United States Patent and Trademark Office, Board of

More information

The Post-Alice Blend Of Eligibility And Patentability

The Post-Alice Blend Of Eligibility And Patentability Portfolio Media. Inc. 111 West 19 th Street, 5th Floor New York, NY 10011 www.law360.com Phone: +1 646 783 7100 Fax: +1 646 783 7161 customerservice@law360.com The Post-Alice Blend Of Eligibility And Patentability

More information

PA Advisors, LLC v. Google Inc. et al Doc. 479 Att. 2 EXHIBIT B. Dockets.Justia.com

PA Advisors, LLC v. Google Inc. et al Doc. 479 Att. 2 EXHIBIT B. Dockets.Justia.com PA Advisors, LLC v. Google Inc. et al Doc. 479 Att. 2 EXHIBIT B Dockets.Justia.com UNITED STATES DISTRICT COURT EASTERN DISTRICT OF TEXAS MARSHALL DIVISION PA ADVISORS, L.L.C., Plaintiff, Civil Action

More information

Title: The patentability criterion of inventive step / non-obviousness

Title: The patentability criterion of inventive step / non-obviousness Question Q217 National Group: China Title: The patentability criterion of inventive step / non-obviousness Contributors: [Heather Lin, Gavin Jia, Shengguang Zhong, Richard Wang, Jonathan Miao, Wilson Zhang,

More information

NAPP Comment to PTO on Quality Case Studies Page 1

NAPP Comment to PTO on Quality Case Studies Page 1 COMMENTS TO THE USPTO ON QUALITY IMPROVEMENT CASE STUDIES Submitted by: The National Association of Patent Practitioners (NAPP) Jeffrey L. Wendt, President Louis J. Hoffman, Chairman of the Board Principal

More information

Fordham 2008 Comparative Obviousness

Fordham 2008 Comparative Obviousness Fordham 2008 Comparative Obviousness John Richards Ladas & Parry LLP E-mail: iferraro@ladas.com What is the purpose of the inventive step requirement? 1. Some subjective reward for brilliance 2. To prevent

More information

The Changing Face of U.S. Patent Litigation

The Changing Face of U.S. Patent Litigation The Changing Face of U.S. Patent Litigation Presented by the IP Litigation Group of Simpson Thacher & Bartlett LLP October 2007 Background on Simpson Thacher Founded 1884 in New York City Now, over 750

More information

We Innovate Healthcare 1

We Innovate Healthcare 1 Kimberly J. Prior Hoffmann-La Roche Inc. December 5, 2012 We Innovate Healthcare 1 The doctrine of obviousness-type double patenting is intended to prevent the extension of the term of a patent by prohibiting

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit 2006-1507 (Serial No. 08/405,454) IN RE JOHN B. SULLIVAN and FINDLAY E. RUSSELL Lawrence M. Green, Wolf, Greenfield & Sacks, P.C., of Boston, Massachusetts,

More information

The use of prosecution history in post-grant patent proceedings

The use of prosecution history in post-grant patent proceedings Question Q229 National Group: United States Title: The use of prosecution history in post-grant patent proceedings Contributors: ADAMO, Kenneth R. ARROYO, Blas ASHER, Robert BAIN, Joseph MEUNIER, Andrew

More information

Inter Partes Review (IPR): Lessons from the First Year Matthew I. Kreeger

Inter Partes Review (IPR): Lessons from the First Year Matthew I. Kreeger Inter Partes Review (IPR): Lessons from the First Year Matthew I. Kreeger mofo.com Inter Partes Review Key distinctive features over inter partes reexamination: Limited Duration Limited Amendment by Patent

More information

Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University

Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University I. Steps in the Process of Declaration of Your Invention or Creation. A. It is the policy of East

More information

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility The Patent Examination Manual Section 10: Meaning of useful An invention, so far as claimed in a claim, is useful if the invention has a specific, credible, and substantial utility. Meaning of useful 1.

More information

KSR v. Teleflex: Obvious Ambiguity

KSR v. Teleflex: Obvious Ambiguity DePaul Journal of Art, Technology & Intellectual Property Law Volume 18 Issue 2 Spring 2008 Article 3 KSR v. Teleflex: Obvious Ambiguity Nicholas Angelocci Follow this and additional works at: https://via.library.depaul.edu/jatip

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit 2007-1074 SCHWARZ PHARMA, INC. and SCHWARZ PHARMA AG, Plaintiffs-Appellants, and WARNER-LAMBERT COMPANY, LLC, Plaintiff, v. PADDOCK LABORATORIES,

More information

Paper Entered: January 11, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Paper Entered: January 11, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Trials@uspto.gov Paper 60 571-272-7822 Entered: January 11, 2016 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD AVX CORPORATION and AVX FILTERS CORPORATION, Petitioner,

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit IN RE RAJEN M. PATEL, GERT CLAASEN, WENBIN LIANG, KARIN KATZER, KENNETH B. STEWART, THOMAS ALLGEUER, AND

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit United States Court of Appeals for the Federal Circuit YEDA RESEARCH AND DEVELOPMENT CO., LTD., Plaintiff-Appellant v. ABBOTT GMBH, Defendant-Appellee 2015-1662 Appeal from the United States District Court

More information

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION RIDDELL, INC., ) ) Plaintiff, ) ) vs. ) Case No. 16 C 4496 ) KRANOS CORPORATION d/b/a SCHUTT ) SPORTS, ) ) Defendant.

More information

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit 2008-1492 (Re-examination No. 90/005,892) IN RE POD-NERS, L.L.C. Dan Cleveland, Jr. Lathrop & Gage, L.C.,

More information

Factors That May Weigh In Favor Of, Or Against, Patentability

Factors That May Weigh In Favor Of, Or Against, Patentability CLIENT MEMORANDUM U.S. PATENT OFFICE PUBLISHES GUIDELINES FOR DETERMINING WHETHER PROCESS CLAIMS COVER ELIGIBLE SUBJECT MATTER IN THE WAKE OF THE SUPREME COURT S BILSKI DECISION The United States Patent

More information

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA. Plaintiffs,

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA. Plaintiffs, 1 1 1 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA IVERA MEDICAL CORPORATION; and BECTON, DICKINSON AND COMPANY, vs. HOSPIRA, INC., Plaintiffs, Defendant. Case No.:1-cv-1-H-RBB ORDER: (1)

More information

FEDERAL CIRCUIT DECISIONS FOR WEEK ENDING AUGUST 25, 2017

FEDERAL CIRCUIT DECISIONS FOR WEEK ENDING AUGUST 25, 2017 P+S FEDERAL CIRCUIT SUMMARIES VOL. 9, ISSUE 35 FEDERAL CIRCUIT DECISIONS FOR WEEK ENDING AUGUST 25, 2017 Icon Health & Fitness, Inc. v. Octane Fitness, LLC, No. 2016-1047, 2016-1101 (August 25, 2017) (nonprecedential)

More information

Successfully Defending Patents In Inter Partes Reexamination And Inter Partes Review Proceedings Before the USPTO. Matthew A. Smith 1 Sept.

Successfully Defending Patents In Inter Partes Reexamination And Inter Partes Review Proceedings Before the USPTO. Matthew A. Smith 1 Sept. Successfully Defending Patents In Inter Partes Reexamination And Inter Partes Review Proceedings Before the USPTO Matthew A. Smith 1 Sept. 15, 2012 USPTO inter partes proceedings are not healthy for patents.

More information

112 Requirements. January Disclosing A Genus Of Compounds. g Supporting A Negative Limitation By Disclosing A Reason To Exclude

112 Requirements. January Disclosing A Genus Of Compounds. g Supporting A Negative Limitation By Disclosing A Reason To Exclude Federal Circuit Review 112 Requirements Volume Four January 2013 In This Issue: g Disclosing A Genus Of Compounds g Supporting A Negative Limitation By Disclosing A Reason To Exclude g Disclosing Two Concurrent

More information

Paper 9 Tel: Entered: August 17, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Paper 9 Tel: Entered: August 17, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Trials@uspto.gov Paper 9 Tel: 571-272-7822 Entered: August 17, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD HOPKINS MANUFACTURING CORPORATION and THE COAST DISTRIBUTION

More information

IP Australia Inventive step legislation and case law in Australia INVENTIVE STEP

IP Australia Inventive step legislation and case law in Australia INVENTIVE STEP INVENTIVE STEP The Australian Patents Act, subsection 7(2) states that an invention is taken to involve an inventive step when compared with the prior art base unless the invention would have been obvious

More information

Petitions and Appeals in the USPTO

Petitions and Appeals in the USPTO Petitions and Appeals in the USPTO William F. Smith Of Counsel Woodcock Washburn LLP 999 Third Avenue, Suite 3600 Seattle, WA 98104-4023 Phone: 206.903.2624 Fax: 206.624.7317 Email: wsmith@woodcock.com

More information

Reviewing Common Themes in Double Patenting. James Wilson, SPE 1624 TC

Reviewing Common Themes in Double Patenting. James Wilson, SPE 1624 TC Reviewing Common Themes in Double Patenting James Wilson, SPE 1624 TC 1600 James.Wilson@uspto.gov 571-272-0661 What is Double Patenting (DP)? Statutory DP Based on 35 USC 101 An applicant (or assignee)

More information